🔗 Visit the ClinicalTrials.gov page for NCT00418327
| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Innovative Therapies for Children with Cancer pediatric phase I study of erlotinib in brainstem glioma and relapsing/refractory brain tumors. | Neuro Oncol | 2010 | 1.22 |
| 2 | Population analysis of erlotinib in adults and children reveals pharmacokinetic characteristics as the main factor explaining tolerance particularities in children. | Clin Cancer Res | 2011 | 0.82 |
| 3 | Advances in paediatric cancer treatment. | Transl Pediatr | 2014 | 0.76 |